Edinoff, A.N.; Nix, C.A.; Odisho, A.S.; Babin, C.P.; Derouen, A.G.; Lutfallah, S.C.; Cornett, E.M.; Murnane, K.S.; Kaye, A.M.; Kaye, A.D.
Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects. Neurol. Int. 2022, 14, 648-663.
https://doi.org/10.3390/neurolint14030053
AMA Style
Edinoff AN, Nix CA, Odisho AS, Babin CP, Derouen AG, Lutfallah SC, Cornett EM, Murnane KS, Kaye AM, Kaye AD.
Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects. Neurology International. 2022; 14(3):648-663.
https://doi.org/10.3390/neurolint14030053
Chicago/Turabian Style
Edinoff, Amber N., Catherine A. Nix, Amira S. Odisho, Caroline P. Babin, Alyssa G. Derouen, Salim C. Lutfallah, Elyse M. Cornett, Kevin S. Murnane, Adam M. Kaye, and Alan D. Kaye.
2022. "Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects" Neurology International 14, no. 3: 648-663.
https://doi.org/10.3390/neurolint14030053
APA Style
Edinoff, A. N., Nix, C. A., Odisho, A. S., Babin, C. P., Derouen, A. G., Lutfallah, S. C., Cornett, E. M., Murnane, K. S., Kaye, A. M., & Kaye, A. D.
(2022). Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects. Neurology International, 14(3), 648-663.
https://doi.org/10.3390/neurolint14030053
